This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Comment: Setback for UK forex-cartel claimants warns others not to take trial approval for granted

By Simon Zekaria ( April 20, 2022, 13:56 GMT | Comment) -- Setbacks for rival UK collective claims against forex cartelist banks warn claimants that winning approval for trial isn’t a slam dunk. This month's Competition Appeal Tribunal ruling faces appeal bids, but the court's deep criticisms of the claims ring alarm bells for claim representatives and other would-be plaintiffs.When two competing UK mass claims aimed at foreign-exchange cartelist banks such as JPMorgan Chase, Barclays and UBS were stymied by competition judges recently, it sent a clear message to claimants in future cases: Don't to be too confident that your suit will be approved for trial....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login